The fine tuning of therapy for chronic myeloid leukemia and upcoming challenges.
Talpaz
Moshe
M
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*
D000970:Antineoplastic Agents